Review summary
Teaching objective: Evaluate chronic epigastric and lower chest pain after meals, with poor appetite and poor sleep, in a 53-year-old man who leads a large organization through a long field assignment, as current guidance advises: exclude a cardiac cause first (an ECG, a structured estimate of the chance of coronary disease, no troponin for chronic pain without an acute episode, and CT coronary angiography chosen by risk); then upper endoscopy with gastric biopsies for Helicobacter pylori, because chest pain without heartburn after a cardiac evaluation calls for objective testing for reflux; reach a diagnosis of erosive reflux esophagitis and say why peptic ulcer and functional dyspepsia were set aside; treat with an eight-week course of a proton pump inhibitor, timed meals and head-of-bed elevation, then step down to on-demand use; review, with respect and without judgment, an unregulated opium-containing herbal remedy he has taken for years (a DSM-5-TR assessment, a drug-monitoring check, a urine drug test with consent, naloxone, no sedatives or alcohol with it, and no forced taper, as the CDC 2022 guideline advises), and recognize how opioids slow the gut; treat chronic insomnia with cognitive behavioral therapy for insomnia rather than hypnotics; and attend to the strain of command. The modern episode is a teaching case, not a claim about the cause of his real complaints, and it does not attribute opioid addiction to him.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| 26 April 121 CE (Julian); 25 April 121 in the proleptic Gregorian calendar | Born at Rome. | CLM-0001 |
| 138 CE | Adopted by Antoninus Pius. | CLM-0002 |
| 161 CE | Becomes emperor, at first jointly with Lucius Verus; Galen later serves at the court. | CLM-0002, CLM-0009 |
| 165 CE | The Antonine Plague begins. | CLM-0004, CLM-0005 |
| About 171 to 175 CE | On campaign on the Danube frontier; writes the Meditations. | CLM-0003, CLM-0008 |
| About 175 CE (the cited translation gives no year) | Hears of the revolt of Avidius Cassius and addresses his soldiers. | CLM-0007 |
| 17 March 180 CE (Julian); 16 March 180 in the proleptic Gregorian calendar | Dies on campaign, at Sirmium or Vindobona; cause unknown. | CLM-0013, CLM-0014 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Marcus Aurelius was born at Rome, in a villa on the Caelian Hill, on the sixth day before the Kalends of May (26 April in the Julian calendar) in 121 CE. | confirmed | Historia Augusta, The Life of Marcus Aurelius, part 1 (Loeb Classical Library, 1921) supports Sellars J. Marcus Aurelius (121-180 C.E.) supports HISTMED Master Roster v3 context |
| D | He was educated in rhetoric by Fronto, was adopted by the emperor Antoninus Pius in 138 CE, became emperor in 161 CE, at first jointly with Lucius Verus, and ruled alone from 169 CE. History only. |
confirmed | Sellars J. Marcus Aurelius (121-180 C.E.) supports |
| D | Much of his reign was spent on campaign in central Europe, and the Meditations were probably written there, about 171 to 175 CE; the first book ends 'Among the Quadi at the Granua' and the second 'This in Carnuntum'. Anchors the index visit on the Danube frontier; the sources do not fix where he was on the true-frame index date. |
probable | Sellars J. Marcus Aurelius (121-180 C.E.) supports Marcus Aurelius, The Meditations, Book One, translated by George Long supports Marcus Aurelius, The Meditations, Book Two, translated by George Long supports |
| D | A great pestilence struck the empire during his reign, from 165 CE, spread with the Parthian war and the wars on the Danube; the Life of Marcus says the dead were removed in carts and wagons and that thousands died, many nobles among them. Galen witnessed the epidemic. History only; the modern sick visit is not a claim about this epidemic. |
confirmed | Sabbatani S, Fiorino S. [The Antonine Plague and the decline of the Roman Empire]. Infez Med 2009;17(4):261-275 (PMID 20046111) supports Historia Augusta, The Life of Marcus Aurelius, part 1 (Loeb Classical Library, 1921) supports |
| R | The cause of the Antonine Plague is uncertain: Galen's case reports suggest smallpox to many authors, but paleopathological confirmation is lacking. Retrospective identification of the epidemic; not coded. |
possible | Sabbatani S, Fiorino S. [The Antonine Plague and the decline of the Roman Empire]. Infez Med 2009;17(4):261-275 (PMID 20046111) supports |
| D | Cassius Dio, a senator of the period, writes that he was so frail in body that at first he could not endure the cold, that he ate very little and only at night, and that by day he took nothing but the drug called theriac, 'not so much because he feared anything, as because his stomach and chest were in bad condition'. The anchor for the presenting problem: chronic stomach and chest complaints. No diagnosis can be made from the description. |
probable | Cassius Dio, Roman History, epitome of Book 72 (71 in some editions), translated by Earnest Cary (Loeb Classical Library, 1927) supports |
| D | In a speech that Dio gives him, addressed to his soldiers after hearing of the revolt of Avidius Cassius, he describes himself as already an old man and weak, 'unable to take either food without pain or sleep without anxiety'. Speeches in ancient histories were composed by the historian; the words are Dio's, but they fit his other descriptions. After the index date, so not linked to the modern episode. |
possible | Cassius Dio, Roman History, epitome of Book 72 (71 in some editions), translated by Earnest Cary (Loeb Classical Library, 1927) supports |
| D | In the Meditations he thanks the gods that remedies were shown to him in dreams, among them remedies 'against bloodspitting and giddiness', and that his body had held out so long in such a kind of life. His own words; the cause of the blood-spitting and giddiness is unknown and is not diagnosed. |
probable | Marcus Aurelius, The Meditations, Book One, translated by George Long supports |
| D | Galen became court physician to the emperors Marcus Aurelius and Lucius Verus, and prepared his theriac at the court; Marcus Aurelius took theriac daily, to protect against poisons and for his general health. Anchors the modern opium-containing remedy. |
probable | Karaberopoulos D, Karamanou M, Androutsos G. The theriac in antiquity. Lancet 2012;379(9830):1942-1943 (PMID 22645742) supports Health and wellbeing in the ancient world, Week 3, section 3.4: Ancient tonics: antidotes supports |
| D | Theriac was a compound remedy of many ingredients, among them viper's flesh, opium, honey, wine and cinnamon. History only. |
confirmed | Karaberopoulos D, Karamanou M, Androutsos G. The theriac in antiquity. Lancet 2012;379(9830):1942-1943 (PMID 22645742) supports |
| D | Galen relates that the emperor disliked the drowsiness the theriac caused, so the poppy juice was left out; he then could not sleep, and the opium-containing preparation was resumed. Read only in a magazine summary of Galen's account (On Antidotes); no scholarly translation was read. Anchors the modern dependence assessment, which is not a claim about him. |
possible | Take some opium and call me in the morning (Miscellany) supports Trancas B, Borja Santos N, Patrício LD. [The use of opium in Roman society and the dependence of Princeps Marcus Aurelius]. Acta Med Port 2008;21(6):581-590 (PMID 19331792) context |
| R | Whether he was dependent on or addicted to opium is disputed. Thomas Africa argued for addiction in 1961; later reviews find no explicit ancient description of opium dependence, call his the one putative case, and favour the most parsimonious reading, that the opium was medicinal rather than hedonic. Disputed retrospective claim; no opioid use disorder is attributed to him and none is coded. |
disputed | Nencini P. The rules of drug taking: wine and poppy derivatives in the Ancient World. VIII. Lack of evidence of opium addiction. Subst Use Misuse 1997;32(11):1581-1586 (PMID 9336867) supports Trancas B, Borja Santos N, Patrício LD. [The use of opium in Roman society and the dependence of Princeps Marcus Aurelius]. Acta Med Port 2008;21(6):581-590 (PMID 19331792) supports Africa TW. The Opium Addiction of Marcus Aurelius. Journal of the History of Ideas 1961;22(1):97-102 (doi:10.2307/2707876) context |
| D | He died on 17 March (Julian) 180 CE, on campaign, at 58; Dio gives his age as fifty-eight years, ten months and twenty-two days. The Life of Marcus says that, eager to die, he refrained from food and drink, worsening the disease, sent his son away for fear he would catch it, and died on the seventh day. Tertullian places his death at Sirmium and Aurelius Victor at Vindobona (Vienna). History only. The place of death is unresolved. |
probable | Cassius Dio, Roman History, epitome of Book 72 (71 in some editions), translated by Earnest Cary (Loeb Classical Library, 1927) supports Historia Augusta, The Life of Marcus Aurelius, part 2, with the editor's notes (Loeb Classical Library, 1921) supports Sellars J. Marcus Aurelius (121-180 C.E.) supports |
| R | The cause of his death is unknown. Dio reports being told that the physicians hastened it to please Commodus; the Life of Marcus suggests a contagious illness, and its editor notes that the plague theory is not well supported. Disputed retrospective explanations; not coded. |
disputed | Cassius Dio, Roman History, epitome of Book 72 (71 in some editions), translated by Earnest Cary (Loeb Classical Library, 1927) supports Historia Augusta, The Life of Marcus Aurelius, part 2, with the editor's notes (Loeb Classical Library, 1921) supports |
| D | As a boy he studied so hard that it impaired his health, which the Life of Marcus calls the only fault to be found in his entire childhood. Past history only; no diagnosis. |
possible | Historia Augusta, The Life of Marcus Aurelius, part 1 (Loeb Classical Library, 1921) supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Burning and pressing pain in the upper abdomen and lower chest after meals, for more than a year and worse over three months, with poor appetite, waking at night with pain and a sour taste, and a 3 kg weight loss; not brought on by exertion; normal ECG; cardiac and peptic causes to be excluded | resolved | confirmed | active | CLM-0006 |
| S | Gastroesophageal reflux disease with erosive esophagitis, Los Angeles grade B, and a 2 cm sliding hiatal hernia; Helicobacter pylori negative on biopsy; coronary disease excluded by CT coronary angiography; synthetic modern diagnosis for his documented stomach and chest complaints | active | confirmed | active | CLM-0006 |
| S | Daily use of an unregulated opium-containing herbal remedy for about six years, for stomach pain and sleep; opioid use disorder criteria not met (one DSM-5-TR criterion, restlessness and poor sleep when he stopped it); expected physiological dependence; constipation and possibly slowed gastric emptying from the opioid | active | confirmed | active | CLM-0009, CLM-0010, CLM-0011 |
| S | Chronic insomnia disorder for more than a year, with waking from night pain and trouble returning to sleep; Insomnia Severity Index 17 (moderate) | active | confirmed | active | CLM-0011 |
| S | Sustained strain of command: leads a large organization through a long field assignment far from home, with long days and little rest | active | confirmed | active | CLM-0003 |
| S | Constipation from the opioid in his remedy: hard stools every two or three days | active | confirmed | active | |
| S | COVID-19, mild (rapid antigen test positive), without breathlessness or low oxygen; antiviral treatment offered and declined; resolved | resolved | confirmed | active |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 2026-05-12 | Hemoglobin [Mass/volume] in Blood | 14.6 g/dL Reference 13.2-17.1 g/dL |
http://loinc.org · 718-7 |
| S | 2026-05-12 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 90 fL Reference 80-100 fL |
http://loinc.org · 787-2 |
| S | 2026-05-12 | Leukocytes [#/volume] in Blood by Automated count | 6.2 10*3/uL Reference 4-11 10*3/uL |
http://loinc.org · 6690-2 |
| S | 2026-05-12 | Platelets [#/volume] in Blood by Automated count | 238 10*3/uL Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 2026-05-12 | Sodium [Moles/volume] in Serum or Plasma | 139 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-05-12 | Potassium [Moles/volume] in Serum or Plasma | 4.3 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-05-12 | Urea nitrogen [Mass/volume] in Serum or Plasma | 14 mg/dL Reference 7-20 mg/dL |
http://loinc.org · 3094-0 |
| S | 2026-05-12 | Creatinine [Mass/volume] in Serum or Plasma | 0.95 mg/dL Reference 0.7-1.3 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-05-12 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 96 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-05-12 | Glucose [Mass/volume] in Serum or Plasma | 92 mg/dL Reference 70-139 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-05-12 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 U/L Reference 7-55 U/L |
http://loinc.org · 1742-6 |
| S | 2026-05-12 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 U/L Reference 8-48 U/L |
http://loinc.org · 1920-8 |
| S | 2026-05-12 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 72 U/L Reference 40-129 U/L |
http://loinc.org · 6768-6 |
| S | 2026-05-12 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.6 mg/dL Reference 0.1-1.2 mg/dL |
http://loinc.org · 1975-2 |
| S | 2026-05-12 | Albumin [Mass/volume] in Serum or Plasma | 4.1 g/dL Reference 3.5-5 g/dL |
http://loinc.org · 1751-7 |
| S | 2026-05-12 | Lipase [Enzymatic activity/volume] in Serum or Plasma | 32 U/L Reference 13-60 U/L |
http://loinc.org · 3040-3 |
| S | 2026-05-12 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4% Reference Below 5.7% is normal; 5.7 to 6.4% prediabetes |
http://loinc.org · 4548-4 |
| S | 2026-05-12 | Cholesterol [Mass/volume] in Serum or Plasma | 205 mg/dL (high) Reference <=199 mg/dL |
http://loinc.org · 2093-3 |
| S | 2026-05-12 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 48 mg/dL Reference >=40 mg/dL |
http://loinc.org · 2085-9 |
| S | 2026-05-12 | Triglyceride [Mass/volume] in Serum or Plasma | 120 mg/dL Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
| S | 2026-05-12 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 133 mg/dL (high) Reference <=129 mg/dL |
http://loinc.org · 13457-7 |
| S | 2026-05-12 | Lipoprotein a [Moles/volume] in Serum or Plasma | 38 nmol/L Reference 125 nmol/L or more adds to cardiovascular risk |
http://loinc.org · 43583-4 |
| S | 2026-05-12 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | http://loinc.org · 44261-6 |
| S | 2026-05-12 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 6 | http://loinc.org · 70274-6 |
| S | 2026-05-12 | Total score [AUDIT-C] | 3 | http://loinc.org · 75626-2 |
| S | 2026-06-16 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | http://loinc.org · 44261-6 |
| S | 2026-08-25 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | http://loinc.org · 44261-6 |
| S | 2026-08-25 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 3 | http://loinc.org · 70274-6 |
| S | 2026-07-28 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | http://loinc.org · 55758-7 |
| S | 2026-07-28 | Total score [AUDIT-C] | 2 | http://loinc.org · 75626-2 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 2026-05-12 | Body height | 172 cm | 8302-2 | S |
| 2026-05-12 | Body weight | 63 kg | 29463-7 | S |
| 2026-05-12 | Body mass index (BMI) [Ratio] | 21.3 kg/m2 | 39156-5 | S |
| 2026-05-12 | Systolic blood pressure | 124 mm[Hg] | 8480-6 | S |
| 2026-05-12 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 2026-05-12 | Heart rate | 76 /min | 8867-4 | S |
| 2026-05-12 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-05-12 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-05-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-05-19 | Body height | 172 cm | 8302-2 | S |
| 2026-05-19 | Body weight | 63.2 kg | 29463-7 | S |
| 2026-05-19 | Body mass index (BMI) [Ratio] | 21.4 kg/m2 | 39156-5 | S |
| 2026-05-19 | Systolic blood pressure | 122 mm[Hg] | 8480-6 | S |
| 2026-05-19 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-05-19 | Heart rate | 74 /min | 8867-4 | S |
| 2026-05-19 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-05-19 | Body temperature | 36.5 Cel | 8310-5 | S |
| 2026-05-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-06-16 | Body height | 172 cm | 8302-2 | S |
| 2026-06-16 | Body weight | 64 kg | 29463-7 | S |
| 2026-06-16 | Body mass index (BMI) [Ratio] | 21.6 kg/m2 | 39156-5 | S |
| 2026-06-16 | Systolic blood pressure | 120 mm[Hg] | 8480-6 | S |
| 2026-06-16 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-06-16 | Heart rate | 72 /min | 8867-4 | S |
| 2026-06-16 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-06-16 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-06-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-08-25 | Body height | 172 cm | 8302-2 | S |
| 2026-08-25 | Body weight | 65 kg | 29463-7 | S |
| 2026-08-25 | Body mass index (BMI) [Ratio] | 22 kg/m2 | 39156-5 | S |
| 2026-08-25 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 2026-08-25 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-08-25 | Heart rate | 70 /min | 8867-4 | S |
| 2026-08-25 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-08-25 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-08-25 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-07-07 | Body height | 172 cm | 8302-2 | S |
| 2026-07-07 | Body weight | 63.6 kg | 29463-7 | S |
| 2026-07-07 | Body mass index (BMI) [Ratio] | 21.5 kg/m2 | 39156-5 | S |
| 2026-07-07 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 2026-07-07 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 2026-07-07 | Heart rate | 94 /min | 8867-4 | S |
| 2026-07-07 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-07-07 | Body temperature | 38.3 Cel | 8310-5 | S |
| 2026-07-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 2026-07-28 | Body height | 172 cm | 8302-2 | S |
| 2026-07-28 | Body weight | 64.4 kg | 29463-7 | S |
| 2026-07-28 | Body mass index (BMI) [Ratio] | 21.8 kg/m2 | 39156-5 | S |
| 2026-07-28 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 2026-07-28 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-07-28 | Heart rate | 70 /min | 8867-4 | S |
| 2026-07-28 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-07-28 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-07-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Leads a large public organization and has spent most of the past several years directing a long field operation far from home, living in temporary quarters near the site; days of twelve hours or more, often with decisions late into the night
- S Writes private reflections in a notebook most nights; reads philosophy; values duty, self-discipline and fairness
- S Tobacco: never. Alcohol: a glass of wine with the evening meal two or three times a week (AUDIT-C 3). No other drugs. Has taken an opium-containing herbal paste most nights for about six years (see medications). No NSAIDs or aspirin
- S Meals: often eats little or nothing by day and one large meal late at night, shortly before lying down
- S Activity: rides and walks the site most days without chest pain or breathlessness
- S Family: has children; his family lives far from the field site. Supports: a few trusted colleagues and his own discipline
Functional status
- S Independent in all activities; works full days; tired by evening
Mental status
- S Courteous, measured and reflective; mood 'tired, but steady'; no hopelessness or thoughts of self-harm; PHQ-9 8 with item 9 scored 0, and GAD-7 6
Structured safety assessment
This assessment is synthetic and does not convert historical behavior into a present-day fact.
Allergies and medications
Allergies
- S No known allergy
Medications
- S Opium-containing compounded herbal paste (an electuary of honey, many herbs and poppy, from an overseas supplier; not prescribed and not regulated, so its morphine content is unknown), about a pea-sized amount (roughly 0.5 g) by mouth at bedtime most nights for about six years, and now and then in the morning before a long day
- S Calcium carbonate 500 mg chewable tablet, one or two tablets as needed for heartburn, no more than six a day, until the endoscopy
- S Polyethylene glycol 3350 powder, 17 g dissolved in a glass of water by mouth once daily as needed for constipation
- S Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose, repeated in 2 to 3 minutes in the other nostril if there is no response; call 911
- S Omeprazole 20 mg delayed-release capsule, one capsule by mouth 30 to 60 minutes before breakfast for eight weeks, for erosive esophagitis
- S Omeprazole 20 mg delayed-release capsule, one capsule by mouth before breakfast on days after heartburn returns (on-demand therapy after the eight-week course)
- S Opium-containing compounded herbal paste (unregulated, strength unknown), about 0.5 g by mouth at bedtime on alternate nights, a reduction he chose and made himself
- S Opium-containing compounded herbal paste (unregulated, strength unknown), a smaller amount, about 0.3 g, by mouth at bedtime on about two nights a week, a further reduction he chose
- S Acetaminophen 500 mg oral tablet, one or two tablets by mouth every six hours as needed for fever or aches, no more than 3 g a day
Procedures and immunizations
Procedures
- S Twelve-lead electrocardiogram at intake: sinus rhythm 76, normal intervals, no ST or T-wave changes, no Q waves
- S CT coronary angiography with coronary calcium scoring (prospectively ECG-gated): coronary calcium score 0, no plaque or stenosis (CAD-RADS 0)
- S Upper endoscopy (esophagogastroduodenoscopy) under moderate sedation
- S Gastric biopsies (two antrum, one incisura, two body; updated Sydney protocol) with a rapid urease test
- S Advance care planning conversation, about 20 minutes
Immunizations
- S 2026-07-28: Pneumococcal conjugate vaccine, 20-valent (PCV20), single dose for an adult aged 50 or older
- S 2026-07-28: Recombinant zoster vaccine (RZV), dose 1 of 2
- S 2026-07-28: Hepatitis B vaccine (HepB-CpG), dose 1 of 2
- S 2026-08-25: Hepatitis B vaccine (HepB-CpG), dose 2 of 2
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D In boyhood (year not recorded): As a boy, study so hard that it impaired his health (no illness named) (CLM-0015)
- D Before the first book of the Meditations, written about 171 to 175 CE: Blood-spitting and giddiness, for which he credits remedies shown to him in dreams (cause not recorded in the cited source) (CLM-0008)
- D During his reign (year not recorded): Frail in body; stomach and chest 'in bad condition'; ate little and only at night; took theriac daily (cause not recorded in the cited source) (CLM-0006, CLM-0009)
Family history
No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| A cardiac cause of the chest pain excluded within two weeks | 2026-05-19 | completed | Normal ECG at intake; CT coronary angiography one week later: calcium score 0 and no plaque |
| Chest and stomach pain after meals controlled, with appetite and weight returning | 2026-08-25 | completed | Pain gone on omeprazole; occasional mild heartburn after late meals on on-demand therapy; weight up 2 kg |
| Insomnia Severity Index below 8 within four months | 2026-08-25 | completed | Insomnia Severity Index 7 after six sessions of CBT-I |
| The remedy used as safely as he can: naloxone at home, never with alcohol or sleep medicines, and decisions about it his own | 2026-08-25 | active | Naloxone at home; no alcohol on nights he takes it; by his own choice now about two nights a week |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Cardiac assessment first: twelve-lead ECG today; a structured estimate of the chance of coronary disease; no troponin, because the pain is chronic and there is no acute episode; CT coronary angiography within a week, chosen over stress testing because it excludes both obstructive and non-obstructive plaque and informs the cholesterol decision; call 911 for chest pain at rest lasting more than a few minutes, or pain with breathlessness, sweating or fainting | completed | GL-AHA-CP-2021, GL-CMID-2026 |
| Gastroenterology consultation for upper endoscopy within one week, with gastric biopsies for Helicobacter pylori, to find the cause of the chest and epigastric pain after the cardiac assessment and to advise on treatment; no acid-suppressing drug before the endoscopy, with an antacid as needed | completed | GL-ACG-GERD-2022, GL-ACG-DYS-2017, GL-ACG-HP-2024 |
| Respectful review of the opium-containing remedy: what it is, why he takes it, and what it does for him; a DSM-5-TR assessment; a prescription drug monitoring program check; a urine drug test with his consent, explained as part of care; naloxone at home; no alcohol, sleep medicines or other sedatives on the same night; never more than his usual amount; stored closed and out of reach; how opioids slow the gut; no forced or abrupt taper, and any reduction his own choice, made slowly; reviewed at every visit, with the 988 Suicide & Crisis Lifeline | completed | GL-CDC-OPIOID-2022 |
| Chronic insomnia: cognitive behavioral therapy for insomnia (CBT-I) with the clinic's behavioral sleep clinician, six sessions, with a sleep diary, sleep restriction, stimulus control and work on racing thoughts at night; Insomnia Severity Index at intake and at each review; no hypnotic or sedating antihistamine, which would add to the opioid | completed | GL-AASM-INS-2021, GL-ACP-INS-2016 |
| Strain of command and mood: PHQ-9 and GAD-7 at intake and at follow-up; protected time for meals and sleep, decisions delegated after a set hour, and his evening writing kept; counselling if scores rise | completed | GL-USPSTF-DEP-2023 |
| Constipation: polyethylene glycol as needed, fluids and fiber; review as the remedy changes | completed | GL-CDC-OPIOID-2022 |
| Reflux esophagitis: omeprazole 20 mg 30 to 60 minutes before breakfast for eight weeks, then a trial off with omeprazole on demand; the evening meal at least three hours before lying down, the head of the bed raised, and less wine at night; no repeat endoscopy for grade B esophagitis; esophageal manometry and reflux monitoring off therapy if symptoms persist or swallowing becomes difficult | completed | GL-ACG-GERD-2022 |
| Mild COVID-19: rest, fluids and acetaminophen; honey for cough; no codeine or dextromethorphan cough medicine, sedating antihistamine or sleep aid while he takes the opium-containing remedy, and no more of the remedy than usual; naloxone at hand; antiviral treatment offered and declined after a shared decision; stay away from others until fever-free for 24 hours without medicine and improving, then added precautions for five days; call 911 for breathlessness, chest pain, confusion or blue lips, and return for oxygen saturation below 94% on a home oximeter | completed | GL-CDC-RESP-2024, GL-CDC-COVIDTX-2025, GL-IDSA-COVID, GL-CDC-OPIOID-2022 |
| Colorectal cancer screening: colonoscopy ordered for the first quiet stretch of his assignment, with a split-dose bowel preparation and two extra days of polyethylene glycol beforehand because the opioid slows the bowel, and no remedy the night before; fecal immunochemical testing each year if he prefers not to have colonoscopy | completed | GL-USPSTF-CRC-2021 |
Planned encounters
- 2026-05-12 — New patient visit for chronic epigastric and lower chest pain after meals, poor appetite and poor sleep: cardiac assessment first, review of an opium-containing remedy, and gastroenterology referral for endoscopy (ENC-001)
- 2026-05-19 — Gastroenterology consultation with upper endoscopy and biopsy, review of the CT coronary angiogram, diagnosis of erosive esophagitis, and start of omeprazole (ENC-002)
- 2026-06-16 — Five-week review: reflux symptoms on omeprazole, biopsy results, sleep therapy, and the remedy (ENC-003)
- 2026-07-07 — Same-day sick visit for mild COVID-19 while taking an opium-containing remedy (ENC-005, unscheduled)
- 2026-07-28 — Periodic adult preventive visit (ENC-006)
- 2026-08-25 — Fifteen-week review after the eight-week omeprazole course: on-demand therapy, sleep, the remedy, and mood (ENC-004)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Sick Visit
- Progress note 05 — Preventive Visit
- Progress note 06 — Focused Visit (Care-plan review)
- Gastroenterology referral
- Gastroenterology consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Sick Visit (XML)
- Progress note 05 — Preventive Visit (XML)
- Progress note 06 — Focused Visit (Care-plan review) (XML)
- Gastroenterology referral (XML)
- Gastroenterology consultation (XML)
Sources
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check the choice of CT coronary angiography over stress testing at a low-to-intermediate chance of coronary disease, endoscopy for chest pain after cardiac evaluation, the diagnosis of erosive esophagitis over peptic ulcer and functional dyspepsia, the eight-week omeprazole course with step-down, the handling of an unregulated opium-containing remedy without a forced taper, and CBT-I without hypnotics. |
| provenance review | not_started | Cassius Dio and the Historia Augusta (Loeb translations on LacusCurtius), the Meditations (Long translation), the Internet Encyclopedia of Philosophy, the Lancet essay on theriac, PubMed abstracts on opium in antiquity and on the Antonine Plague, an Open University course page and a Lapham's Quarterly summary logged. Galen's On Antidotes, the letters to Fronto and Africa's 1961 article were not read in a reliable translation or in full. |
| safe messaging review | not_started | Claims about his opium use are marked sensitive; the addiction claim is graded R, disputed, and no opioid use disorder is attributed to him. The modern remedy review is non-judgmental and patient-led. His death is recorded briefly. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.